Mbx Biosciences, Inc. · NASDAQ:MBX
Smither John W received 28,000 Mbx Biosciences, Inc. shares as an award (Form 4)
Traded Aug 3, 2026 · Filed Aug 4, 2026
On Aug 3, 2026, Smither John W (Chief Financial Officer) received 28,000 Mbx Biosciences, Inc. shares as an award, leaving 28,000 shares. Filed Aug 4, 2026 (Form 4).
- Awarded
- 28,000 shares
- Holding after
- 28,000 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | Award | 28,000 | 28,000 | Direct |
Source
Related
- Mbx Biosciences, Inc.
- Smither John W
- Mbx Biosciences, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Aug 10, 2026
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Hoerter Steven L. · Aug 4, 2026